You have 2 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenocarcinoma

Showing 1 - 25 of 8,125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Local and Peripheral Immune Responsive Landscape Induced by

Not yet recruiting
  • Lung Adenocarcinoma
  • Local Cryoablation
    • (no location specified)
    Oct 24, 2023

    Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))

    Not yet recruiting
    • Gastric Adenocarcinoma
    • cadonilimab combined +paclitaxel (albumin-bound)
    • (no location specified)
    Nov 1, 2023

    Lung Adenocarcinoma, Frozen Section, Sublobar Resection Trial in Shanghai (Sublobar Resection)

    Recruiting
    • Lung Adenocarcinoma
    • +2 more
    • Sublobar Resection
    • Shanghai, Shanghai, China
      Fudan University Cancer Center
    Sep 4, 2023

    Colorectal Adenocarcinoma Trial in Padova (Impact Oral®)

    Not yet recruiting
    • Colorectal Adenocarcinoma
    • Impact Oral®
    • Padova, Italy
      Istituto Oncologico Veneto IRCCS
    Nov 10, 2023

    HER-2 Expression in Pancreatic Duct Adenocarcinoma

    Completed
    • Pancreatic Adenocarcinoma
    • immunohistochemical approach
    • (no location specified)
    Sep 20, 2023

    Esophagogastric Adenocarcinoma Trial (Sacituzumab govitecan)

    Not yet recruiting
    • Esophagogastric Adenocarcinoma
    • Sacituzumab govitecan
    • (no location specified)
    Nov 9, 2023

    Tumor Microenvironment

    Active, not recruiting
    • Lung Adenocarcinoma
      • (no location specified)
      Aug 5, 2023

      Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction Trial

      Not yet recruiting
      • Adenocarcinoma Esophagus
      • +3 more
      • (no location specified)
      Sep 13, 2023

      Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Oligometastatic Disease
      • FOLFIRINOX chemotherapy
      • Baltimore, Maryland
        Johns Hopkins Hospital
      Nov 2, 2023

      Lung Adenocarcinoma Trial in Shijiazhuang (Tislelizumab,Platinum)

      Recruiting
      • Lung Adenocarcinoma
      • Shijiazhuang, Hebei, China
        The Fourth Hospital of Hebei Medical University (Hebei Tumor Hos
      Sep 24, 2023

      Gastroesophageal Adenocarcinoma Trial (Paclitaxel, Ramucirumab, Zanidatamab)

      Not yet recruiting
      • Gastroesophageal Adenocarcinoma
      • (no location specified)
      Sep 12, 2023

      Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)

      Not yet recruiting
      • Adenocarcinoma - GEJ
      • Gastric Adenocarcinoma
      • (no location specified)
      Sep 26, 2023

      Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Boston (other, diagnostic test, combination product)

      Not yet recruiting
      • Pancreatic Cancer
      • +4 more
      • Screening Blood Tests
      • +3 more
      • Boston, Massachusetts
      • +1 more
      Nov 3, 2023

      Ethmoid Sinus Tumor, Adenocarcinoma, Circulating Tumor Cell Trial (Liquid biopsy)

      Not yet recruiting
      • Ethmoid Sinus Tumor
      • +2 more
      • Liquid biopsy
      • (no location specified)
      Oct 18, 2023

      Pancreas Cancer, Pancreas Adenocarcinoma Trial in Cleveland (Capecitabine)

      Not yet recruiting
      • Pancreas Cancer
      • Pancreas Adenocarcinoma
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Seidman Cancer Ce
      Oct 29, 2023

      Bile Duct Adenocarcinoma Trial in Hangzhou (surufatinib plus cadonilimab)

      Recruiting
      • Bile Duct Adenocarcinoma
      • surufatinib plus cadonilimab
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Oct 15, 2023

      IA Lung Adenocarcinoma, Combined Segmentectomy Trial in Fuzhou (Patients receive subsegmentectomy)

      Active, not recruiting
      • IA Lung Adenocarcinoma
      • Combined Segmentectomy
      • Patients receive subsegmentectomy
      • Fuzhou, China
        Fujian Medical University Union Hospital
      Aug 2, 2023

      Anatomical-Clinical Base of Adenocarcinoma Pancreatic

      Recruiting
      • Adenocarcinoma
      • +2 more
      • collection of biological samples
      • Bordeaux, France
      • +7 more
      Nov 20, 2023

      Tumor Size and Prognosis in Small Bowel adenocarcinoma-a

      Completed
      • Prognosis
      • no interventions
      • Dalian, Liaoning, China
        Dalian Third People's Hospital Affiliated to Dalian Medical Univ
      Oct 11, 2023

      Pancreatic Ductal Adenocarcinoma, Pain, Acute Trial in San Francisco (Ketamine, Meaning and Purpose therapy)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Pain, Acute
      • San Francisco, California
        University of California, San Francisco
      Oct 12, 2023

      Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be

      Recruiting
      • Ductal Adenocarcinoma of the Pancreas
      • Whipple over the splenic artery
      • Total pancreatectomy
      • Taipei, Taiwan
        National Taiwan University Hospital
      Nov 1, 2023

      Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

      Not yet recruiting
      • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
      • (no location specified)
      Jul 17, 2023

      Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)

      Not yet recruiting
      • Gastric
      • Colorectal Adenocarcinoma
      • Shenyang, Liaoning, China
        Liaoning Cancer Hospital & Institute
      Nov 1, 2023

      Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Serplulimab)

      Recruiting
      • Gastroesophageal Junction Adenocarcinoma
      • Beijing, China
        Peking Union Medical College Hospital
      Jun 15, 2023

      Minimal Residual Disease Using Multi-omics Approach

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
      • Shanghai, China
        Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
      Nov 29, 2023